More about

Idiopathic Pulmonary Fibrosis

News
January 27, 2021
2 min read
Save

ILD year in review: New guidelines, FDA approvals and more

ILD year in review: New guidelines, FDA approvals and more

The Healio editors have compiled a list of the most-read news on interstitial lung diseases published in 2020.

News
January 13, 2021
2 min read
Save

Concomitant statin therapy yields benefit on IPF progression

Concomitant statin therapy yields benefit on IPF progression

Statin therapy may have a significant benefit on progression of idiopathic pulmonary fibrosis, according to results of a retrospective study published in Respiratory Medicine.

News
December 17, 2020
1 min read
Save

Mortality due to COVID-19 elevated in patients with preexisting ILD

Mortality due to COVID-19 elevated in patients with preexisting ILD

Mortality due to COVID-19 was higher in patients with preexisting fibrotic idiopathic interstitial lung disease compared with other interstitial lung diseases, researchers reported in a new study.

News
December 08, 2020
2 min read
Save

Oral co-trimoxazole fails to reduce adverse outcomes in patients with IPF

Oral co-trimoxazole fails to reduce adverse outcomes in patients with IPF

Treatment with oral co-trimoxazole did not reduce time to death, lung transplant or nonelective hospitalization compared with placebo in patients with moderate or severe idiopathic pulmonary fibrosis in the EME-TIPAC trial.

News
September 04, 2020
1 min read
Save

No treatment benefit with pirfenidone plus sildenafil for IPF, pulmonary hypertension

No treatment benefit with pirfenidone plus sildenafil for IPF, pulmonary hypertension

Combination therapy with pirfenidone plus sildenafil did not provide treatment benefit in patients with advanced idiopathic pulmonary fibrosis and risk for pulmonary hypertension compared with pirfenidone plus placebo.

News
August 27, 2020
2 min read
Save

ATS guideline addresses challenges in diagnosing hypersensitivity pneumonitis

ATS guideline addresses challenges in diagnosing hypersensitivity pneumonitis

The American Thoracic Society issued a new clinical practice guideline to aid clinicians in diagnosing hypersensitivity pneumonitis in patients with newly diagnosed interstitial lung disease — the first new guidance in 3 decades.

News
August 14, 2020
2 min read
Save

Nintedanib analyses support benefit in chronic fibrosing ILDs with progressive phenotype

Nintedanib analyses support benefit in chronic fibrosing ILDs with progressive phenotype

New analyses of the INBUILD trial show nintedanib slowed lung function decline and reduced the annual rate of FVC decline in patients with a progressive form of chronic fibrosing interstitial lung diseases, including in various subgroups.

News
July 09, 2020
2 min read
Save

Online home monitoring improves psychological well-being in patients with IPF

Online home monitoring improves psychological well-being in patients with IPF

A comprehensive online home monitoring program for patients with idiopathic pulmonary fibrosis did not improve health-related quality of life, but improved patients’ psychological well-being.

News
April 28, 2020
1 min read
Save

Systemic Sclerosis With Pulmonary Involvement: Improving Diagnosis and Advances in Treatment

Systemic sclerosis (SSc) is a disabling autoimmune disorder that can cause diffuse fibrosis and vascular abnormalities in the skin, joints, and internal organs. Affecting approximately 2 million people worldwide, SSc is challenging to diagnose due to its nonspecific symptomatology and rare nature.

News
March 09, 2020
1 min read
Save

FDA approves first treatment for progressive ILDs

FDA approves first treatment for progressive ILDs

The FDA has approved the first treatment — nintedanib oral capsules — to treat patients with chronic fibrosing interstitial lung diseases with a progressive phenotype, according to a press release from the agency.

View more